458 related articles for article (PubMed ID: 2863192)
1. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
[TBL] [Abstract][Full Text] [Related]
2. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
[TBL] [Abstract][Full Text] [Related]
3. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
[TBL] [Abstract][Full Text] [Related]
4. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
5. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
Nishida A; Yuki H; Tsutsumi R; Miyata K; Kamato T; Ito H; Yamano M; Honda K
Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760
[TBL] [Abstract][Full Text] [Related]
6. The effect of dibutyryl cyclic guanosine monophosphate, a competitive antagonist to cholecystokinin-pancreozymin, on gastric acid secretion in the isolated mouse stomach.
Davison JS; Najafi-Farashah A
Life Sci; 1982 Jul; 31(4):355-61. PubMed ID: 6128663
[TBL] [Abstract][Full Text] [Related]
7. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
Stubbs RS; Stabile BE
Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.
Hirst BH; Elliott KJ; Ryder H; Szelke M
Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479
[TBL] [Abstract][Full Text] [Related]
10. Effects of various gastrointestinal peptides on parietal cells and endocrine cells in the oxyntic mucosa of rat stomach.
El Munshid HA; Håkanson R; Liedberg G; Sundler F
J Physiol; 1980 Aug; 305():249-65. PubMed ID: 6108365
[TBL] [Abstract][Full Text] [Related]
11. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenous secretin and cholecystokinin in intraduodenal oleic acid-induced inhibition of gastric acid secretion in rats.
Shiratori K; Watanabe S; Takeuchi T
Dig Dis Sci; 1992 Mar; 37(3):397-402. PubMed ID: 1735364
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin receptor antagonism of stimulated pancreatic and gastric secretion.
Mulholland MW; Debas HT
J Surg Res; 1989 Nov; 47(5):460-4. PubMed ID: 2478762
[TBL] [Abstract][Full Text] [Related]
14. Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation.
Nealon WH; Beauchamp RD; Townsend CM; Thompson JC
Am J Surg; 1987 Jan; 153(1):96-101. PubMed ID: 3799899
[TBL] [Abstract][Full Text] [Related]
15. Secretagogue-specific effects of interleukin-1 on gastric acid secretion.
Wallace JL; Cucala M; Mugridge K; Parente L
Am J Physiol; 1991 Oct; 261(4 Pt 1):G559-64. PubMed ID: 1681735
[TBL] [Abstract][Full Text] [Related]
16. Selective action of a CCK-B/gastrin receptor antagonist, S-0509, on pentagastrin-, peptone meal- and beer-stimulated gastric acid secretion in dogs.
Sasaki N; Matsuno K; Okabe S
Aliment Pharmacol Ther; 2000 Apr; 14(4):479-88. PubMed ID: 10759628
[TBL] [Abstract][Full Text] [Related]
17. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
Hills DM; Gerskowitch VP; Roberts SP; Welsh NJ; Shankley NP; Black JW
Br J Pharmacol; 1996 Dec; 119(7):1401-10. PubMed ID: 8968549
[TBL] [Abstract][Full Text] [Related]
19. Characterization of in vivo acid secretory responses of rabbit with comparison to dog and rat.
Mulvihill SJ; Pappas TN; Debas HT
Dig Dis Sci; 1989 Jun; 34(6):895-904. PubMed ID: 2566457
[TBL] [Abstract][Full Text] [Related]
20. Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release.
Gerber JG; Payne NA
J Pharmacol Exp Ther; 1996 Nov; 279(2):718-23. PubMed ID: 8930176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
